On this episode of Investor Connect, Hall welcomes Dr. Christian Apfel, founder at Sage Medic. SageMedic is advancing functional precision oncology through its core platform, the Sage OncoTest, which uses a patient’s live tumor tissue to create 3D micro-tumors and test therapies directly against the tumor’s biology to generate a sensitivity and resistance profile across chemotherapies and targeted therapies, including dose-response and both cytotoxicity and anti-proliferation effects. Christian Apfel is a licensed physician, clinical researcher, life sciences investor, and entrepreneur with more than 100 publications, including work in the New England Journal of Medicine, and he previously led a clinical outcomes research group at UCSF. He shares how his father’s lung cancer experience and low response-rate realities in standard care drove him to pursue functional testing, why genomic matching often falls short (including NCI MATCH results and sub-50% response even with targetable mutations), and how adoption, guidelines, reimbursement lag, CLIA/LDT readiness, MRD testing, and a planned Series A1 trial strategy shape the path to broader clinical use, with resources at sagemedic.com. Visit SageMedic at http://www.sagemedic.com Reach out to at http://www.linkedin.com/in/chrisapfel, and on capfel@sagemedic.com ________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.
Copyright (c) 2026, Hall Martin and investorconnect.org. All rights reserved.
Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.










